Phialogics

Switzerland
Allschwil, Basel-Landschaft, Switzerland, 4123

Company profile

Phialogics company profile

Phialogics is a preclinical biotech business with a focus on developing next-generation biologics to balance the immune response in both acute and long-term inflammation.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2021-01-01, Year

Headquarters

Postal code
4123
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$657,108
Last funding
Grant / $549,451 / 2023-10-06
Last equity funding
Pre Seed / $657,108
Investors
2
Lead investors
2
Articles
2

Founders and investors

Lead investors

BaseLaunchHTGF (High-Tech Gruenderfonds)

Investors

BaseLaunchHTGF (High-Tech Gruenderfonds)